Multipotent mesenchymal stromal cells and immune tolerance

被引:110
|
作者
Noel, Daniele
Djouad, Farida
Bouffi, Carine
Mrugala, Dominique
Jorgensen, Christian
机构
[1] INSERM, U844, Montpellier, France
[2] Univ Montpellier I, UFR Med, Montpellier, France
[3] Hop St Eloi, Unite Therapie Cellulaire & Genique, Montpellier, France
[4] NIH, Cartilage Biol & Orthopaed Branch, Bethesda, MD USA
[5] Hop Lapeyronie, Serv Immunol Rhumatol, Montpellier, France
关键词
mesenchymal stem cell; immunosuppression; characterization;
D O I
10.1080/10428190701361869
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Multipotent mesenchymal stromal cells or mesenchymal stem cells ( MSC) are isolated mainly from bone marrow and adipose tissue but are identified in other tissues such as synovium, periosteum or placenta. They are characterised by their property to adhere to plastic, their phenotype and their ability to differentiate into three lineages ( chondrocytes, osteoblasts and adipocytes). More recently, these cells were shown to escape immune recognition and inhibit immune responses. MSC may modulate the function of the major immune cell populations, including antigen-presenting cells, T cells, B cells and natural killer cells. The aim of this review is to focus on the molecular mechanisms, still poorly understood, which are responsible of the immunosuppressive effects mediated by the MSC. Finally, the data obtained from in vivo experimentation in various animal models as well as potential therapeutic applications will be presented.
引用
收藏
页码:1283 / 1289
页数:7
相关论文
共 50 条
  • [41] Bone Marrow Transplantation Combined with Mesenchymal Stem Cells Induces Immune Tolerance without Cytotoxic Conditioning
    Wang, Yunchuan
    Liu, Jiaqi
    Xu, Chengfeng
    Zhang, Wanfu
    Bai, Li
    Li, Na
    Liu, Yang
    Wang, Yaojun
    Su, Yingjun
    Hu, Dahai
    JOURNAL OF SURGICAL RESEARCH, 2011, 171 (01) : E123 - E131
  • [42] Therapeutic application of mesenchymal stromal cells in autoimmune disease
    Keysser, G.
    Mueller, L.
    Schendel, M.
    Schmoll, H. -J.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2009, 68 (03): : 220 - +
  • [43] Mesenchymal stromal cells for the treatment of ocular autoimmune diseases
    Oh, Joo Youn
    Lee, Ryang Hwa
    PROGRESS IN RETINAL AND EYE RESEARCH, 2021, 85
  • [44] Current understanding of the immunosuppressive properties of mesenchymal stromal cells
    Ligia Lins de Castro
    Miquéias Lopes-Pacheco
    Daniel Jay Weiss
    Fernanda Ferreira Cruz
    Patricia Rieken Macêdo Rocco
    Journal of Molecular Medicine, 2019, 97 : 605 - 618
  • [45] Current understanding of the immunosuppressive properties of mesenchymal stromal cells
    de Castro, Ligia Lins
    Lopes-Pacheco, Miqueias
    Weiss, Daniel Jay
    Cruz, Fernanda Ferreira
    Macedo Rocco, Patricia Rieken
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2019, 97 (05): : 605 - 618
  • [46] Therapeutic application of mesenchymal stromal cells in autoimmune disease
    Keysser, G.
    Mueller, L.
    Schendel, M.
    Schmoll, H. -J.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2009, 68 (03): : 220 - +
  • [47] Dexamethasone has variable effects on mesenchymal stromal cells
    Wang, Hanyu
    Pang, Bo
    Li, Yan
    Zhu, Delin
    Pang, Tianxiang
    Liu, Yongjun
    CYTOTHERAPY, 2012, 14 (04) : 423 - 430
  • [48] Critical View on Mesenchymal Stromal Cells in Regenerative Medicine
    Langrzyk, Agnieszka
    Nowak, Witold N.
    Stepniewski, Jacek
    Jazwa, Agnieszka
    Florczyk-Soluch, Urszula
    Jozkowicz, Alicja
    Dulak, Jozef
    ANTIOXIDANTS & REDOX SIGNALING, 2018, 29 (02) : 169 - 190
  • [49] The use of mesenchymal stromal cells in oncology and cell therapy
    Pommey, Sandra
    Galipeau, Jacques
    BULLETIN DU CANCER, 2006, 93 (09) : 901 - 907
  • [50] The assessment of the in vivo to in vitro cellular transition of human umbilical cord multipotent stromal cells
    Coskun, H.
    Can, A.
    PLACENTA, 2015, 36 (02) : 232 - 239